IAS Injecting Drug Use Research Prizes
The inaugural IAS Injecting Drug Use Research Prizes will be awarded at AIDS 2018.
The three US$2,000 IAS Injecting Drug Use Research Prizes are awarded by the IAS HIV Co-Infections and Co-Morbidities initiative. They are incentives for researchers to address important research questions around the management of HCV infection and/or HIV/HCV co-infection in people who inject drugs, in particular through interdisciplinary research on drug dependence, harm reduction and/or drug policy. The prizes are presented to the three top-scoring abstracts in any of these areas.
Eligible candidates are presenting authors of abstracts submitted to AIDS 2018, which meet the following criteria:
- The Conference Advisory Committee has accepted the abstract as an oral presentation, a poster discussion session or the poster exhibition.
- The research demonstrates innovation, originality, rationale and quality.
- The title or abstract body contains at least two of the following keywords: “injecting drug use”, “people who inject drugs”, “PWID”, “HCV”, “addiction”, “dependence”, “harm reduction” and “drug policy”.
- The research presented in the abstract is interdisciplinary and considers the management of HCV infection and/or HIV/HCV co-infection in people who inject drugs, in particular around drug dependence, harm reduction and/or drug policy issues.
Abstract submitters do not need to apply for the prize.
All abstracts that meet the criteria will be automatically considered.